• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GUIDANT CRM CLONMEL IRELAND DYNAGEN; IMPLANTABLE CHF GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GUIDANT CRM CLONMEL IRELAND DYNAGEN; IMPLANTABLE CHF GENERATOR Back to Search Results
Model Number G158
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 04/27/2018
Event Type  malfunction  
Manufacturer Narrative
No additional information is available.If additional information becomes available the report will be updated at that time.
 
Event Description
Boston scientific received information that the patient reported to the clinic that the red light was flashing on the remote home monitor.Patient services attempted to contact the patient to assist in troubleshooting why the home monitor was not sending data to the clinic, however the patient did not answer the phone.A message was left, but not returned.The clinic was informed that the red light may indicate an alert that was detected and not able to be transmitted to the clinic.It was suggested to have the patient perform another remote interrogation since the monitor had connected within the last 24 hours.At this time the reason for the red light is unknown and the cardiac resynchronization therapy defibrillator (crt-d) remains in service.No adverse patient effects were reported.
 
Manufacturer Narrative
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
Additional information was received from the clinic that this patient was seen in the office and the decision was made by the patient and physician to turn off tachycardia therapies.The clinic stated the patient called shortly after the visit asking about the red light on the remote home monitor.The clinic stated the red light was due to the fact tachycardia therapy had been programmed off.The clinic has opted to do in clinic visits moving forward.The cardiac resynchronization therapy defibrillator (crt-d) remain in service and no adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN
Type of Device
IMPLANTABLE CHF GENERATOR
Manufacturer (Section D)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer (Section G)
GUIDANT CRM CLONMEL IRELAND
guidant ireland
clonmel, tipperary ireland
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515826168
MDR Report Key7617279
MDR Text Key111657011
Report Number2124215-2018-09297
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534904
UDI-Public00802526534904
Combination Product (y/n)N
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/08/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/20/2017
Device Model NumberG158
Other Device ID NumberDYNAGEN X4 CRT-D
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 04/27/2018
Initial Date FDA Received06/19/2018
Supplement Dates Manufacturer Received06/08/2018
Supplement Dates FDA Received06/28/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/20/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age87 YR
-
-